恒瑞医药关于与Novo Nordisk A/S签署HRS-1596项目授权许可协议的公告
600276 Jiangsu Hengrui Pharmaceuticals恒瑞医药Shanghai Stock Exchange
12 posts
Jiangsu Hengrui Pharmaceuticals (600276) at a glance
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
Jiangsu Hengrui Pharmaceuticals (600276) share price over the last 3 months
Over the last 3 months (Jun 30 – Sep 30), Jiangsu Hengrui Pharmaceuticals traded between a high of CN¥57.50 (Jul 15) and a low of CN¥42.67 (Sep 11). It closed at CN¥47.20 on Sep 30, −9.3% from 3 months ago and +2.5% from a month ago.
3-month highCN¥57.50Jul 15
3-month lowCN¥42.67Sep 11
vs 1 month ago+2.5%vs Aug 31
vs 3 months ago−9.3%vs Jun 30
Closing prices, last 10 trading days
| Date | Close | Change | % Change |
|---|---|---|---|
| Sep 30 (Wed) | CN¥47.20 | +1.58 | +3.46% |
| Sep 29 (Tue) | CN¥45.62 | +1.15 | +2.59% |
| Sep 28 (Mon) | CN¥44.47 | −0.39 | −0.87% |
| Sep 24 (Thu) | CN¥44.86 | −0.72 | −1.58% |
| Sep 23 (Wed) | CN¥45.58 | −0.14 | −0.31% |
| Sep 22 (Tue) | CN¥45.72 | −0.32 | −0.70% |
| Sep 21 (Mon) | CN¥46.04 | +2.13 | +4.85% |
| Sep 18 (Fri) | CN¥43.91 | +0.68 | +1.57% |
| Sep 17 (Thu) | CN¥43.23 | −0.29 | −0.67% |
| Sep 16 (Wed) | CN¥43.52 | +0.39 | +0.90% |
Daily closing prices from Yahoo! Finance. Always check the latest price before trading.
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.
No.12
Disclosure
2026/09/29 09:00
契約の締結
恒瑞医药关于与Novo Nordisk A/S签署HRS-1596项目授权许可协议的公告
恒瑞医药关于与Novo Nordisk A/S签署HRS-1596项目授权许可协议的公告
No.11
Disclosure
2026/09/25 09:00
株主総会決議
恒瑞医药2026年第一次临时股东会决议公告
恒瑞医药2026年第一次临时股东会决议公告
Delete
No.10
Disclosure
2026/09/25 09:00
株主総会
恒瑞医药2026年第一次临时股东会法律意见书
恒瑞医药2026年第一次临时股东会法律意见书
Delete
No.9
Disclosure
2026/09/24 09:00
新薬・製品の承認
恒瑞医药关于获得药物临床试验批准通知书的公告
恒瑞医药关于获得药物临床试验批准通知书的公告
Delete
No.8
Disclosure
2026/09/22 09:00
新薬・製品の承認
恒瑞医药关于获得药物临床试验批准通知书的公告
恒瑞医药关于获得药物临床试验批准通知书的公告
Delete
No.7
Disclosure
2026/09/22 09:00
新薬・製品の承認
恒瑞医药关于获得药物临床试验批准通知书的公告
恒瑞医药关于获得药物临床试验批准通知书的公告
Delete
No.6
Disclosure
2026/09/22 09:00
新薬・製品の承認
恒瑞医药关于获得药物临床试验批准通知书的公告
恒瑞医药关于获得药物临床试验批准通知书的公告
Delete
No.5
Disclosure
2026/09/19 09:00
株主総会
恒瑞医药2026年第一次临时股东会会议资料
恒瑞医药2026年第一次临时股东会会议资料
Delete
No.4
Disclosure
2026/09/18 09:00
自社株買い
恒瑞医药关于首次回购公司A股股份的公告
恒瑞医药关于首次回购公司A股股份的公告
Delete
No.3
Disclosure
2026/09/16 09:00
新薬・製品の承認
恒瑞医药关于获得药物临床试验批准通知书的公告
恒瑞医药关于获得药物临床试验批准通知书的公告
Delete
No.2
Disclosure
2026/09/16 09:00
新薬・製品の承認
恒瑞医药关于获得药物临床试验批准通知书的公告
恒瑞医药关于获得药物临床试验批准通知书的公告
Delete
No.1
Disclosure
2026/09/15 09:00
新薬・製品の承認
恒瑞医药关于药品上市许可申请获受理的提示性公告
恒瑞医药关于药品上市许可申请获受理的提示性公告
Delete
Write on the Jiangsu Hengrui Pharmaceuticals board
More Chinese stocks in English
- Kweichow Moutai600519
- Wuliangye Yibin000858
- Ping An Insurance (A-share)601318
- China Merchants Bank600036
- Midea Group000333
- CATL (Contemporary Amperex Technology)300750
- BYD (A-share)002594
- LONGi Green Energy601012
- ICBC (A-share)601398
- China Construction Bank (A-share)601939
- Agricultural Bank of China601288
- Bank of China (A-share)601988